Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92.2M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
57M
-
Shares change
-
+53.1M
-
Total reported value, excl. options
-
$114M
-
Value change
-
+$107M
-
Number of buys
-
27
-
Number of sells
-
-12
-
Price
-
$2.01
Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q2 2024
43 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57M shares
of 92.2M outstanding shares and own 61.87% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (7.42M shares), Avidity Partners Management LP (7.42M shares), Nextech Invest Ltd. (7.42M shares), GREAT POINT PARTNERS LLC (7.42M shares), Blue Owl Capital Holdings LP (5.16M shares), VANGUARD GROUP INC (4.5M shares), Driehaus Capital Management LLC (2.26M shares), Alyeska Investment Group, L.P. (1.94M shares), Nantahala Capital Management, LLC (1.94M shares), and Ally Bridge Group (NY) LLC (1.89M shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.